Adebrelimab Maintenance Therapy for LS-SCLC Post Induction Chemo-Adebrelimab Plus CRT or CRT Alone

NCT07381543 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Localized Small Cell Lung Cancer

Interventions

DRUG: Adebrelimab Induction Therapy Group
DRUG: Adebrelimab Maintenance Therapy Group

Sponsor

Peking University Cancer Hospital & Institute